Clinical Trial Update: Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nivolumab to docetaxel in previously treated metastatic non-squamous non-small cell lung cancer has completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-Squamous Cell Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-02-26